Invention Grant
- Patent Title: Use of MVA to treat prostate cancer
- Patent Title (中): 使用MVA治疗前列腺癌
-
Application No.: US12253094Application Date: 2008-10-16
-
Publication No.: US07867483B2Publication Date: 2011-01-11
- Inventor: Alain Delcayre , Reiner Laus , Stefanie Mandl , Ryan Blair Rountree , Fatema Legrand
- Applicant: Alain Delcayre , Reiner Laus , Stefanie Mandl , Ryan Blair Rountree , Fatema Legrand
- Applicant Address: US CA Mountain View
- Assignee: BN Immunotherapeutics, Inc.
- Current Assignee: BN Immunotherapeutics, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Law Office of Salvatore Arrigo
- Main IPC: A61K35/00
- IPC: A61K35/00 ; C12N15/63
Abstract:
The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane.
Public/Granted literature
- US20090104225A1 USE OF MVA TO TREAT PROSTATE CANCER Public/Granted day:2009-04-23
Information query
